期刊文献+

糖皮质激素诱导的亮氨酸拉链对特发性血小板减少性紫癜凋亡的影响

Effect of Glucocorticoid Induced Leucine Zipper on Apoptosis of Idiopathic Thrombocytopenic Purpura
原文传递
导出
摘要 目的:研究糖皮质激素诱发的亮氨酸拉链蛋白(GILZ)在特发性血小板减少性紫癜发病机制中的作用。方法:收集已确诊的特发性血小板减少性紫癜(ITP)患者抗凝血26例,利用密度梯度离心法获取外周血单个核细胞(PBMCs),并将PBMCs分为地塞米松(DEX)干预组及空白对照组,相同条件培养48h。采用逆转录-酶联聚合反应(RT-PCR)法检测各组PBMCs中GILZ mRNA及Bcl-2mRNA的表达;酶联免疫吸附法(ELISA)检测Bcl-2蛋白表达量。结果:在10-7 mol/L DEX刺激下,DEX刺激组ITP患者PBMCs的GILZ mRNA表达水平高于空白对照组(P<0.05);DEX刺激组Bcl-2mRNA及Bcl-2蛋白的表达量低于空白对照组(P<0.05)。结论:糖皮质激素可有效上调GILZ基因表达;GILZ的高表达可以下调Bcl-2表达量,具有促进凋亡的作用。 Objective: To investigate the mechanism of the action of glucocorticoid induced leucine zipper(GILZ) in idiopathic thrombocytopenic purpura.Methods: The peripheral blood mononuclear cells(PBMCs) were segregated from twenty six idiopathic thrombocytopenic purpura patients.In one group the cells were treated with dexamethasone(DEX),while in another group the cells were treated with PBS.Forty eight hours later total RNA were abstracted in both two groups.Reverse transcription polymerase chain reaction(RT-PCR) was used to analysis the expression of GILZ mRNA and Bcl-2 mRNA in PBMCs from both groups.Enzyme linked immunosorbent assay(ELISA) was used to analysis the expression of Bcl-2 protein.Results: The medium GILZ mRNA was increased in idiopathic thrombocytopenic purpura patients at DEX group when compared with controls(P0.05).Levels of Bcl-2 mRNA and Bcl-2 protein expression decreased in DEX group(P0.05).Conclusion: DEX is an effective stimulator of GILZ production.Overexpression of GILZ can decrease Bcl-2 concentration in idiopathic thrombocytopenic purpura patients,suggesting that GILZ may have therapeutic value for immunity diseases,such as idiopathic thrombocytopenic purpura.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2012年第2期272-274,279,共4页 Medical Journal of Wuhan University
关键词 糖皮质激素 亮氨酸拉链 特发性血小板减少性紫癜 凋亡 Glucocorticoid Leucine Zipper Idiopathic Thrombocytopenic Purpura Apoptosis
  • 相关文献

参考文献10

二级参考文献39

  • 1侯明,秦平.欧美国家特发性血小板减少性紫癜诊治意见介绍[J].中华血液学杂志,2005,26(3):191-192. 被引量:17
  • 2秦平,陈峰,张春青,彭军,陈学良,侯明.大剂量地塞米松治疗慢性特发性血小板减少性紫癜的疗效观察[J].中华内科杂志,2005,44(6):451-452. 被引量:46
  • 3武永吉.多发性骨髓瘤[M]//张之南,沈悌.血液病诊断及疗效标准.3版.北京:科学出版社,2007:232-235.
  • 4Schiemann B,Gommerman JL,Vora K,et al.An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.Science,2001,293:2111-2114.
  • 5O'Connor BP,Raman VS,Erickson LD,et al.BCMA is essential for the survival of long-lived bone marrow plasma cells.J Exp Med.2004.199:91-97.
  • 6Emmerich F,Bal G,Barakat A,et al.High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.Br J Haematol,2007,136:309-314.
  • 7Yu J,Heck S,Patel V,et al.Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura.Blood,2008,112:1325-1328.
  • 8Rodeghiero F,Stasi R,Gernsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an intemational working group.Blood,2009,113:2386-2393.
  • 9Stohl W,Metyas S,Tan SM,et al.B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus:longitudinal observations.Arthritis Rheum.2003,48:3475-3486.
  • 10Seyler TM,Park YW,Takemura S,et al.BLyS and APRIL in rheumatoid arthritis.J Clin Invest.2005,115:3083-3092.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部